Foresite Capital Management Iv, LLC Ascendis Pharma A/S Transaction History

Foresite Capital Management Iv, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$97.01 - $145.11 $6.69 Million - $10 Million	-68,981 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$91.45 - $139.12 $16.1 Million - $24.5 Million	-176,443 Reduced 71.89%	68,981 $9.6 Million
Q3 2018 Nov 13, 2018	SELL	$63.77 - $76.28 $1.59 Million - $1.91 Million	-25,000 Reduced 9.24%	245,424 $17.4 Million
Q2 2018 Aug 14, 2018	SELL	$58.55 - $73.92 $12 Million - $15.2 Million	-204,995 Reduced 43.12%	270,424 $18 Million
Q1 2018 May 15, 2018	SELL	$38.98 - $68.04 $2.1 Million - $3.67 Million	-53,924 Reduced 10.19%	475,419 $31.1 Million
Q4 2017 Feb 13, 2018	BUY	$31.98 - $40.38 $16.9 Million - $21.4 Million	529,343	529,343 $21.2 Million

226

56.6M

142K

259K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $6.85B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.